Logo image of FATH

FATHOM DIGITAL MANUFACTURING (FATH) Stock Fundamental Analysis

NYSE:FATH - New York Stock Exchange, Inc. - US31189Y2028 - Common Stock - Currency: USD

5.05  -0.22 (-4.17%)

Fundamental Rating

2

Overall FATH gets a fundamental rating of 2 out of 10. We evaluated FATH against 127 industry peers in the Machinery industry. FATH may be in some trouble as it scores bad on both profitability and health. FATH is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

FATH had negative earnings in the past year.
In the past year FATH has reported a negative cash flow from operations.
In multiple years FATH reported negative net income over the last 5 years.
In multiple years FATH reported negative operating cash flow during the last 5 years.
FATH Yearly Net Income VS EBIT VS OCF VS FCFFATH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -100M -200M -300M -400M

1.2 Ratios

FATH has a Return On Assets of 4.87%. This is comparable to the rest of the industry: FATH outperforms 56.92% of its industry peers.
With an excellent Return On Equity value of 22.14%, FATH belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
Industry RankSector Rank
ROA 4.87%
ROE 22.14%
ROIC N/A
ROA(3y)-41.95%
ROA(5y)-26.99%
ROE(3y)-378.05%
ROE(5y)-230.36%
ROIC(3y)N/A
ROIC(5y)N/A
FATH Yearly ROA, ROE, ROICFATH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 -200 -400 -600 -800 -1K

1.3 Margins

With an excellent Profit Margin value of 12.23%, FATH belongs to the best of the industry, outperforming 82.31% of the companies in the same industry.
FATH has a Gross Margin (28.70%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of FATH has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 12.23%
GM 28.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.55%
GM growth 5YN/A
FATH Yearly Profit, Operating, Gross MarginsFATH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -100 -200 -300

More info and screens

1

2. Health

2.1 Basic Checks

FATH does not have a ROIC to compare to the WACC, probably because it is not profitable.
FATH has more shares outstanding than it did 1 year ago.
The debt/assets ratio for FATH is higher compared to a year ago.
FATH Yearly Shares OutstandingFATH Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 1M 2M 3M
FATH Yearly Total Debt VS Total AssetsFATH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

FATH has an Altman-Z score of -2.43. This is a bad value and indicates that FATH is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -2.43, FATH is not doing good in the industry: 85.38% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.03 indicates that FATH is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.03, FATH belongs to the best of the industry, outperforming 80.77% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -2.43
ROIC/WACCN/A
WACC8.6%
FATH Yearly LT Debt VS Equity VS FCFFATH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 0.22 indicates that FATH may have some problems paying its short term obligations.
The Current ratio of FATH (0.22) is worse than 97.69% of its industry peers.
FATH has a Quick Ratio of 0.22. This is a bad value and indicates that FATH is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.16, FATH is not doing good in the industry: 96.92% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.16
FATH Yearly Current Assets VS Current LiabilitesFATH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

FATH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 101.40%, which is quite impressive.
The Revenue for FATH has decreased by -18.50% in the past year. This is quite bad
Measured over the past years, FATH shows a very strong growth in Revenue. The Revenue has been growing by 28.90% on average per year.
EPS 1Y (TTM)101.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-211.25%
Revenue 1Y (TTM)-18.5%
Revenue growth 3Y28.9%
Revenue growth 5YN/A
Sales Q2Q%-16.6%

3.2 Future

FATH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.42% yearly.
The Revenue is expected to grow by 12.36% on average over the next years. This is quite good.
EPS Next Y-71.29%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.3%
Revenue Next 2Y12.36%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
FATH Yearly Revenue VS EstimatesFATH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
FATH Yearly EPS VS EstimatesFATH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 -2 -4 -6 -8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

FATH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FATH Price Earnings VS Forward Price EarningsFATH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

71.54% of the companies in the same industry are cheaper than FATH, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 27.92
FATH Per share dataFATH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 -20

4.3 Compensation for Growth

A more expensive valuation may be justified as FATH's earnings are expected to grow with 41.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for FATH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FATHOM DIGITAL MANUFACTURING

NYSE:FATH (5/20/2024, 8:04:01 PM)

5.05

-0.22 (-4.17%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-15 2024-05-15/amc
Earnings (Next)08-12 2024-08-12/bmo
Inst Owners0.09%
Inst Owner Change0%
Ins Owners70.19%
Ins Owner Change0%
Market Cap34.69M
Analysts45.71
Price Target4.85 (-3.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-26.58%
Min EPS beat(2)-100%
Max EPS beat(2)46.85%
EPS beat(4)3
Avg EPS beat(4)-2.37%
Min EPS beat(4)-100%
Max EPS beat(4)46.85%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.63%
Min Revenue beat(2)-5.06%
Max Revenue beat(2)-4.2%
Revenue beat(4)2
Avg Revenue beat(4)-0.52%
Min Revenue beat(4)-5.06%
Max Revenue beat(4)5.13%
Revenue beat(8)2
Avg Revenue beat(8)-2.34%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.26
P/FCF N/A
P/OCF N/A
P/B 0.48
P/tB N/A
EV/EBITDA 27.92
EPS(TTM)-6.68
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.97
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS19.11
BVpS10.56
TBVpS-23.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.87%
ROE 22.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 12.23%
GM 28.7%
FCFM N/A
ROA(3y)-41.95%
ROA(5y)-26.99%
ROE(3y)-378.05%
ROE(5y)-230.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.55%
GM growth 5YN/A
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.28
Cap/Depr 19.86%
Cap/Sales 3.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.22
Quick Ratio 0.16
Altman-Z -2.43
F-Score3
WACC8.6%
ROIC/WACCN/A
Cap/Depr(3y)42.27%
Cap/Depr(5y)35.26%
Cap/Sales(3y)5.96%
Cap/Sales(5y)4.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)101.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-211.25%
EPS Next Y-71.29%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.5%
Revenue growth 3Y28.9%
Revenue growth 5YN/A
Sales Q2Q%-16.6%
Revenue Next Year-1.3%
Revenue Next 2Y12.36%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year193.26%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y34.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-153.47%
OCF growth 3YN/A
OCF growth 5YN/A